Insider · CIK 0001532303
Eric Schoen
Files at FLNA (CASSAVA SCIENCES INC). First filing Dec 3, 2024, latest Dec 3, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FLNA: CASSAVA SCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | CASSAVA SCIENCES INC | $238k 61,800 shares | -3090% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 2, 2024 | FLNA CASSAVA SCIENCES INC | 2,000 0.00% of outstanding | $7,640 | Nov 29, 2024 | $231k |
| Nov 29, 2024 | FLNA CASSAVA SCIENCES INC | 59,800 0.12% of outstanding | $231k | Nov 29, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 17, 2025 | FLNA CASSAVA SCIENCES INC | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Apr 21, 2025 |
| Nov 29, 2024 | FLNA CASSAVA SCIENCES INC | MOption exercise Common Stock | +50,000 | $1.18 | $59k | 71,300 | Dec 3, 2024 |
| Nov 29, 2024 | FLNA CASSAVA SCIENCES INC | SOpen-market sale Common Stockindirect: By limited liability corporation | -2,000 | $3.82 | $7,640 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | FLNA CASSAVA SCIENCES INC | SOpen-market sale Common Stock | -59,800 | $3.86 | $231k | 11,500 | Dec 3, 2024 |
| Nov 29, 2024 | FLNA CASSAVA SCIENCES INC | MOption exercise Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.